Videos by Topic
- Addiction | Alcohol | Drugs
- Adolescents
- Athletics | Exercise
- Babies | Pregnancy | Fetus | Embryo
- Cancer
- Children
- COVID-19
- Diseases | Disorders | Conditions | Syndromes
- Food | Obesity
- Girls ♀ Women
- Infections | Immune System
- Injury | Pain | Violence
- Medication | Treatment | Therapy | Surgery
- Mental Health | Wellbeing | Stress | Sleep
- Myths | Fake News | Science Mistrust
- Physical Health | Human Body | Sex
- Products | Supplements
- Racism | Inequality
- Science
- Technology
- #Shorts
Addiction | Alcohol | Drugs
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Adolescents
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Athletics | Exercise
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Pregnancy
The process by which a female produces an offspring in their womb once the male and female zygotes have combined into a single embryo until birth.
Embryo
The offspring in the womb, from the moment 2 zygotes co-exist up until the 11th week of pregnancy, is medically referred to as "Embryo"
Fetus
The offspring in the womb, beginning on the 11th week of pregnancy, has graduated from "Embryo" to "Fetus"
Newborn
The offspring, now emerged from the womb and ending the female's pregnancy.
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Cancer
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Children
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
COVID-19
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Disease
An abnormality caused due to pathophysiological response to external or internal factors.
Disorder
A disruption in normal functioning of mind or body due to a disease, genetic factor or trauma.
Syndrome
A set or collection of various identifying signs and symptoms that characterizes a certain disease or disorder.
Condition
An abnormal state of physical or mental health that interferes with usual activities or the feeling of well-being.
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Food | Obesity
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Girls ♀ Women
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Infections | Immune System
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Injury | Pain | Violence
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Medication | Treatment | Therapy | Surgery
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Mental Health | Wellbeing | Stress | Sleep
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Myths | Fake News | Science Mistrust
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Physical Health | Human Body | Sex
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Products | Supplements
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Racism | Inequality
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Science
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
Technology
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
YouTube #Shorts
Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski
Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.
With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.
[Please complete our feedback form]
/general-use/logos/external-group-logos/news-aoda.jpg?sfvrsn=f93f9048_2)